FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313492004> ?p ?o ?g. }

• W4313492004 endingPage "e12665" @default.
• W4313492004 startingPage "e12665" @default.
• W4313492004 abstract "In the wake of economic challenges, the role of generic medicines has become crucial in meeting the healthcare needs of people. Their use, however, can only be guaranteed if established to be bioequivalent to their corresponding innovator products.In this study, we assess the suitability of a generic brand of cetirizine hydrochloride tablet to be used in place of the innovator brand on the Ghanaian market through bioequivalence assessment.An HPLC bioanalytical method was developed and validated for the detection and quantitation of cetirizine in a urine matrix. This was then used to quantify the amount of cetirizine excreted unchanged in urine samples of 12 healthy male volunteers collected over a 24-h period using a two-way crossover design approach.Chromatographic separation was successfully achieved with an isocratic elution on a reverse-phase column. The mean retention time for cetirizine was 2.890 ± 0.243 min. The mean cumulative amounts of cetirizine in the reference and test drugs excreted were 5.69 ± 0.98 mg and 5.82 ± 1.96 mg respectively. Other pharmacokinetic parameters including mean relative Areas Under Curve (AUC0-24) of 13.32 and 13.05 μg/mL, and peak Concentration (Cmax) of 3.378 and 3.043 μg/mL at the times at which Cmax was observed (Tmax) being 7.25 and 7.42 min were established respectively for the reference and test drugs. The relative bioavailability was determined to be 102.28, making the locally manufactured brand bioequivalent to the innovator brand.The locally manufactured test Cetirizine drug was found to be bioequivalent with the innovator brand and could serve as a suitable alternative to the latter. Additionally, relevant pharmacokinetic parameters for cetirizine has been established using urinary excretion data." @default.
• W4313492004 created "2023-01-06" @default.
• W4313492004 creator A5000288673 @default.
• W4313492004 creator A5043913686 @default.
• W4313492004 creator A5050074944 @default.
• W4313492004 creator A5055501885 @default.
• W4313492004 creator A5080987464 @default.
• W4313492004 creator A5088088279 @default.
• W4313492004 date "2023-01-01" @default.
• W4313492004 modified "2023-09-29" @default.
• W4313492004 title "Bioequivalence studies of cetirizine tablets using the urine excretion data of healthy Ghanaian male volunteers" @default.
• W4313492004 cites W1678221914 @default.
• W4313492004 cites W1978677256 @default.
• W4313492004 cites W2106532703 @default.
• W4313492004 cites W2128417596 @default.
• W4313492004 cites W2129872180 @default.
• W4313492004 cites W2898092274 @default.
• W4313492004 cites W2901453410 @default.
• W4313492004 cites W3050567479 @default.
• W4313492004 cites W3101738047 @default.
• W4313492004 cites W3122698449 @default.
• W4313492004 cites W4283020639 @default.
• W4313492004 cites W612582571 @default.
• W4313492004 cites W819824124 @default.
• W4313492004 doi "https://doi.org/10.1016/j.heliyon.2022.e12665" @default.
• W4313492004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36691524" @default.
• W4313492004 hasPublicationYear "2023" @default.
• W4313492004 type Work @default.
• W4313492004 citedByCount "0" @default.
• W4313492004 crossrefType "journal-article" @default.
• W4313492004 hasAuthorship W4313492004A5000288673 @default.
• W4313492004 hasAuthorship W4313492004A5043913686 @default.
• W4313492004 hasAuthorship W4313492004A5050074944 @default.
• W4313492004 hasAuthorship W4313492004A5055501885 @default.
• W4313492004 hasAuthorship W4313492004A5080987464 @default.
• W4313492004 hasAuthorship W4313492004A5088088279 @default.
• W4313492004 hasBestOaLocation W43134920041 @default.
• W4313492004 hasConcept C111919701 @default.
• W4313492004 hasConcept C112705442 @default.
• W4313492004 hasConcept C142724271 @default.
• W4313492004 hasConcept C181389837 @default.
• W4313492004 hasConcept C185592680 @default.
• W4313492004 hasConcept C203014093 @default.
• W4313492004 hasConcept C204787440 @default.
• W4313492004 hasConcept C22979827 @default.
• W4313492004 hasConcept C27081682 @default.
• W4313492004 hasConcept C2776473838 @default.
• W4313492004 hasConcept C2779463773 @default.
• W4313492004 hasConcept C2780008190 @default.
• W4313492004 hasConcept C2780026642 @default.
• W4313492004 hasConcept C33923547 @default.
• W4313492004 hasConcept C34974158 @default.
• W4313492004 hasConcept C41008148 @default.
• W4313492004 hasConcept C42404028 @default.
• W4313492004 hasConcept C43617362 @default.
• W4313492004 hasConcept C55493867 @default.
• W4313492004 hasConcept C71924100 @default.
• W4313492004 hasConcept C87813604 @default.
• W4313492004 hasConcept C98274493 @default.
• W4313492004 hasConceptScore W4313492004C111919701 @default.
• W4313492004 hasConceptScore W4313492004C112705442 @default.
• W4313492004 hasConceptScore W4313492004C142724271 @default.
• W4313492004 hasConceptScore W4313492004C181389837 @default.
• W4313492004 hasConceptScore W4313492004C185592680 @default.
• W4313492004 hasConceptScore W4313492004C203014093 @default.
• W4313492004 hasConceptScore W4313492004C204787440 @default.
• W4313492004 hasConceptScore W4313492004C22979827 @default.
• W4313492004 hasConceptScore W4313492004C27081682 @default.
• W4313492004 hasConceptScore W4313492004C2776473838 @default.
• W4313492004 hasConceptScore W4313492004C2779463773 @default.
• W4313492004 hasConceptScore W4313492004C2780008190 @default.
• W4313492004 hasConceptScore W4313492004C2780026642 @default.
• W4313492004 hasConceptScore W4313492004C33923547 @default.
• W4313492004 hasConceptScore W4313492004C34974158 @default.
• W4313492004 hasConceptScore W4313492004C41008148 @default.
• W4313492004 hasConceptScore W4313492004C42404028 @default.
• W4313492004 hasConceptScore W4313492004C43617362 @default.
• W4313492004 hasConceptScore W4313492004C55493867 @default.
• W4313492004 hasConceptScore W4313492004C71924100 @default.
• W4313492004 hasConceptScore W4313492004C87813604 @default.
• W4313492004 hasConceptScore W4313492004C98274493 @default.
• W4313492004 hasIssue "1" @default.
• W4313492004 hasLocation W43134920041 @default.
• W4313492004 hasLocation W43134920042 @default.
• W4313492004 hasLocation W43134920043 @default.
• W4313492004 hasOpenAccess W4313492004 @default.
• W4313492004 hasPrimaryLocation W43134920041 @default.
• W4313492004 hasRelatedWork W2349338867 @default.
• W4313492004 hasRelatedWork W2351830309 @default.
• W4313492004 hasRelatedWork W2356698425 @default.
• W4313492004 hasRelatedWork W2357220270 @default.
• W4313492004 hasRelatedWork W2363111155 @default.
• W4313492004 hasRelatedWork W2374069256 @default.
• W4313492004 hasRelatedWork W2387133671 @default.
• W4313492004 hasRelatedWork W2387566090 @default.
• W4313492004 hasRelatedWork W2392383498 @default.
• W4313492004 hasRelatedWork W48952282 @default.
• W4313492004 hasVolume "9" @default.

• next